z-logo
Premium
Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours
Author(s) -
Sabattini S.,
Barzon G.,
Giantin M.,
Lopparelli R. M.,
Dacasto M.,
Prata D.,
Bettini G.
Publication year - 2017
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/vco.12246
Subject(s) - mast cell , receptor tyrosine kinase , tyrosine kinase , receptor , mast (botany) , cancer research , chemistry , medicine , pathology , immunology
This study investigated Kit receptor dysregulations (cytoplasmic immunohistochemical expression and/or c‐ KIT mutations) in cats affected with splenic mast cell tumours. Twenty‐two cats were included. Median survival time was 780 days (range: 1–1219). An exclusive splenic involvement was significantly ( P = 0.042) associated with longer survival (807 versus 120 days). Eighteen tumours (85.7%) showed Kit cytoplasmic expression (Kit pattern 2, 3). Mutation analysis was successful in 20 cases. Fourteen missense mutations were detected in 13 out of 20 tumours (65%). Eleven (78.6%) were located in exon 8, and three (21.6%) in exon 9. No mutations were detected in exons 11 and 17. Seven mutations corresponded to the same internal tandem duplication in exon 8 (c.1245_1256dup). Although the association between Kit cytoplasmic expression and mutations was significant, immunohistochemistry cannot be considered a surrogate marker for mutation analysis. No correlation was observed between c‐Kit mutations and tumour differentiation, mitotic activity or survival.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here